Trial no.:
|
PACTR201503001068335 |
Date of Approval:
|
11/03/2015 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effect of adding dexmeditomidine to epidural bupivacaine |
Official scientific title |
A dose reduction study of local anesthetic with addition of dexmedetomidine on postoperative epidural analgesia for patients undergoing total knee arthroplasty |
Brief summary describing the background
and objectives of the trial
|
Postoperative pain after total knee arthroplasty is a major interest. Epidural analgesia still the preferred method of postoperative analgesia for total knee arthroplasty in many countries. Dexmedetomidine is a new alpha-2 agonist which had many beneficial effects when administered epidurally. The aim of study was to provide effective postoperative analgesia with hemodynamic stability through reduction of the amount of local anaesthetic administered epidurally by using epidural new adjunct dexmedetomidine. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,knee arthroplasty ,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/01/2012 |
Actual trial start date |
08/01/2012 |
Anticipated date of last follow up |
01/01/2014 |
Actual Last follow-up date |
01/01/2014 |
Anticipated target sample size (number of participants) |
75 |
Actual target sample size (number of participants) |
75 |
Recruitment status |
Completed |
Publication URL |
|
|